Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)

Summary

The National Institutes of Health (NIH) is soliciting R01 research grant applications focused on the development of neuromodulation and neurostimulation devices for mental health applications. Clinical trials are explicitly excluded from this funding opportunity. The program seeks to advance device-based approaches targeting psychiatric or neurological conditions. The opportunity is open from November 2024 through January 2028, indicating a multi-cycle funding announcement (PAR) with multiple submission deadlines.

What they want

How they evaluate

Risks & flags

• Extremely long open window (over 3 years) typical of NIH Program Announcement with Review (PAR) — not a red flag per se, but response deadlines rotate and applicants must check specific due dates
• Clinical trials explicitly excluded, which significantly narrows eligible applicant pool to pre-clinical/non-clinical researchers